You have 9 free searches left this month | for more free features.

Family history breast cancer and ovarian cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lynch Syndrome, Colorectal Cancer, Breast Cancer Trial in Oakland (online cancer risk assessment, Usual care)

Recruiting
  • Lynch Syndrome
  • +5 more
  • online cancer risk assessment
  • Usual care
  • Oakland, California
    Division of Research, Kaiser Permanente Northern California
Dec 7, 2022

Cancer, Breast, Cancer, Ovarian, Cancer, Colorectal Trial in Toronto (FHAMe Intervention)

Active, not recruiting
  • Cancer, Breast
  • +6 more
  • FHAMe Intervention
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Aug 10, 2022

Risk Communication Within Mexican-American Families

Completed
  • Breast Cancer
  • +3 more
  • Family Health History
  • Houston, Texas
    MD Anderson Cancer Center
Jan 13, 2023

FH-Risk 2.0: Updating Breast Cancer Risk Estimates

Recruiting
  • Breast Cancer Risk
  • Notification of a revised breast cancer risk estimate
  • Manchester, Greater Manchester, United Kingdom
    Manchester University NHS Foundation Trust
Dec 17, 2022

Shanghai Ovarian Cancer and Family Care Project

Recruiting
  • Ovarian Cancer
    • Shanghai, Shanghai, China
      Shanghai first maternity and infant hospital
    Oct 31, 2023

    l, Laboratory and Epidemiologic Characterization of Individuals

    Completed
    • Familial Ovarian Cancer
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 31, 2022

      Removal of Ovaries/Fallopian Tubes and CA-125 Screening to

      Completed
      • Breast Cancer
      • Ovarian Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 28, 2022

        Genetic Predisposition to Disease, Breast Cancer Female, Ovarian Cancer Trial in Philadelphia (Sequential EHR Communications)

        Not yet recruiting
        • Genetic Predisposition to Disease
        • +6 more
        • Sequential EHR Communications
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Feb 8, 2023

        Breast Cancer, Breast Tumors, Breast Cancer Female Trial in United States (contrast-enhanced mammography)

        Recruiting
        • Breast Cancer
        • +3 more
        • contrast-enhanced mammography
        • Bethel Park, Pennsylvania
        • +4 more
        Oct 23, 2023

        Breast & Ovarian Cancer Risk Detection

        Recruiting
        • Adnexal Mass
        • +3 more
        • OVA360
        • Austin, Texas
          Silvana Franco
        Jul 20, 2022

        Lung Cancer Trial in Hong Kong (Low dose CT thorax)

        Recruiting
        • Lung Cancer
        • Low dose CT thorax
        • Hong Kong, Hong Kong
          University of Hong Kong
        Mar 6, 2023

        Young Patients With Early Breast Cancer

        Not yet recruiting
        • Breast Cancer Female
        • operation
        • (no location specified)
        Sep 6, 2023

        Breast Cancer After Ovarian Cancer During and/or After Therapy:

        Recruiting
        • BRCA-Associated Breast Carcinoma
        • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
        • Rome, RM, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Mar 9, 2023

        Endocrine Disruptors and Life STILe in Breast Cancer Development

        Recruiting
        • Breast Cancer
        • +5 more
          • Roma, Italy
            Alessandra Fabi
          Feb 25, 2023

          Breast Cancer Trial in Manchester (Low dose mammogram)

          Completed
          • Breast Cancer
          • Low dose mammogram
          • Manchester, United Kingdom
            The Nightingale Centre
          Mar 21, 2023

          Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

          Not yet recruiting
          • Prostate Cancer
          • +11 more
          • Guided physical exercise
          • +2 more
          • Tampere, Länsi-Suomi, Finland
            Tampere University Hospital
          Apr 3, 2023

          Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)

          Not yet recruiting
          • Breast Cancer
          • Ovarian Function Suppression + Aromatase Inhibitor
          • Adjuvant Chemotherapy + Ovarian Function Suppression
          • (no location specified)
          May 19, 2023

          Genetic Predisposition to Disease Trial in Buffalo (Family History education, Patient Ambassador)

          Recruiting
          • Genetic Predisposition to Disease
          • Family History education
          • Patient Ambassador
          • Buffalo, New York
            SUNY Buffalo
          Dec 29, 2021

          Breast Cancer and Other Gynecologic Malignancies

          Enrolling by invitation
          • Breast Cancer
          • +2 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Aug 18, 2022

            Dyad's Perspectives on Treatment Decision, Financial and Family

            Recruiting
            • Breast Cancer
              • Taipei, Taiwan
                National Taiwan University Hospital
              Jun 15, 2023

              HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

              Active, not recruiting
              • HER2-positive Breast Cancer
              • +8 more
              • pNGVL3-hICD vaccine
              • +6 more
              • Seattle, Washington
                Fred Hutchinson Cancer Research Center/University of Washington
              Nov 1, 2022

              Breast Cancer Female Trial (Vaginal Lactobacillus capsules)

              Not yet recruiting
              • Breast Cancer Female
              • Vaginal Lactobacillus capsules
              • (no location specified)
              Aug 2, 2023

              Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

              Not yet recruiting
              • Hormone-receptor-positive Breast Cancer
              • +3 more
              • Aromatase inhibitor
              • +3 more
              • Guangzhou, Guangdong, China
                Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
              Apr 5, 2023

              Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

              Not yet recruiting
              • Advanced Fallopian Tube Carcinoma
              • +10 more
              • Wee1 Inhibitor ZN-c3
              • Portland, Oregon
                OHSU Knight Cancer Institute
              Jan 25, 2023

              Breast Cancer Female, Breast Cancer, Breast Tumors Trial in Cranberry Township, Monroeville, Pittsburgh (Contrast-enhanced

              Recruiting
              • Breast Cancer Female
              • +3 more
              • Contrast-enhanced mammogram
              • Cranberry Township, Pennsylvania
              • +2 more
              Sep 2, 2022